Literature DB >> 15637134

Circulating adiponectin and plasma fatty acid profile.

José-Manuel Fernández-Real1, Joan Vendrell, Wifredo Ricart.   

Abstract

BACKGROUND: The amount and type of fat in the diet influence the development of obesity and related inflammatory activity. Knowledge of the possible influence of dietary habits on circulating adiponectin, a molecule with putative antiinflammatory properties, may be helpful in preventing atherosclerosis and type 2 diabetes.
METHODS: The association between dietary fat, as inferred from plasma fatty acid composition (gas-liquid chromatography), and circulating adiponectin (RIA) was evaluated in 116 healthy individuals.
RESULTS: The proportion of saturated fatty acids in plasma was significantly associated with circulating adiponectin concentration (r = -0.24; P = 0.01). Specifically, percentage of palmitic acid (C16:0) was significantly associated with lower adiponectin concentration (r = -0.28; P = 0.002), particularly among women (r = -0.37; P = 0.02) and nonsmokers (r = -0.30; P = 0.007). Percentage of myristic acid (C14:0) was also significantly associated with lower adiponectin among nonsmokers (r = -0.26; P = 0.02) and women (r = -0.39; P = 0.01). The other fatty acids were not significantly associated with adiponectin except for eicosanoic acid (C20:1 omega-9), which was significantly and positively associated with adiponectin in all individuals (r = 0.23; P = 0.01). This latter association was most significant in smokers (r = 0.43; P = 0.007). In a multivariate regression analysis to predict circulating adiponectin, after controlling for age, body mass index, waist-to-hip ratio, and the individual remaining fatty acids, the percentages of palmitic (P = 0.005) and eicosanoic acid (P = 0.03) contributed independently (6% and 3%, respectively) to adiponectin variance. Among nonsmokers, the percentages of palmitic acid (P = 0.01) and omega-3 fatty acids contributed 8% and 7%, respectively, to adiponectin variance. Among smokers, the percentage of eicosanoic acid (P = 0.03) contributed to 10% of adiponectin variance, independently of body mass index, age, waist-to hip ratio, and the remaining individual fatty acids.
CONCLUSIONS: Saturated and omega-3 fatty acids of dietary origin (as inferred from plasma fatty acid concentration) are associated with circulating adiponectin concentrations in healthy humans. The proportion of eicosanoic acid also appears to be positively associated with circulating adiponectin. The knowledge of how these interactions occur may be helpful in the planning of dietary measures aimed at the modulation of inflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637134     DOI: 10.1373/clinchem.2004.041350

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  21 in total

1.  Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet.

Authors:  P Flachs; V Mohamed-Ali; O Horakova; M Rossmeisl; M J Hosseinzadeh-Attar; M Hensler; J Ruzickova; J Kopecky
Journal:  Diabetologia       Date:  2006-01-06       Impact factor: 10.122

2.  Erythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men.

Authors:  Cornelia Enzenbach; Janine Kröger; Vera Zietemann; Eugène H J M Jansen; Andreas Fritsche; Frank Döring; Heiner Boeing; Matthias B Schulze
Journal:  Eur J Nutr       Date:  2011-02-08       Impact factor: 5.614

3.  Metabolic syndrome affects fatty acid composition of plasma lipids in obese prepubertal children.

Authors:  Mercedes Gil-Campos; Maria del Carmen Ramírez-Tortosa; Elvira Larqué; Javier Linde; Concepción M Aguilera; Ramón Cañete; Angel Gil
Journal:  Lipids       Date:  2008-07-01       Impact factor: 1.880

4.  Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults.

Authors:  A Ramel; A Martinéz; M Kiely; G Morais; N M Bandarra; I Thorsdottir
Journal:  Diabetologia       Date:  2008-05-20       Impact factor: 10.122

Review 5.  Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.

Authors:  Michael M Swarbrick; Peter J Havel
Journal:  Metab Syndr Relat Disord       Date:  2008-06       Impact factor: 1.894

6.  Effects of flaxseed oil supplementation on plasma adiponectin levels in dyslipidemic men.

Authors:  George K Paschos; Antonis Zampelas; Demosthenes B Panagiotakos; Stergios Katsiougiannis; Bruce A Griffin; Vasilios Votteas; Fotini N Skopouli
Journal:  Eur J Nutr       Date:  2007-07-11       Impact factor: 5.614

7.  A Dietary Pattern Derived from Reduced Rank Regression and Fatty Acid Biomarkers Is Associated with Lower Risk of Type 2 Diabetes and Coronary Artery Disease in Chinese Adults.

Authors:  Jowy Y H Seah; Choon Nam Ong; Woon-Puay Koh; Jian-Min Yuan; Rob M van Dam
Journal:  J Nutr       Date:  2019-11-01       Impact factor: 4.798

8.  Relationship among adiponectin, adiponectin gene expression and fatty acids composition in morbidly obese patients.

Authors:  Juan Jose Hernandez-Morante; Fermin Ignacio Milagro; Elvira Larque; Juan Lujan; Jose Alfredo Martinez; Salvador Zamora; Marta Garaulet
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

9.  Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease.

Authors:  Rocio Aller; Daniel A de Luis; Luis Fernandez; Fernando Calle; Benito Velayos; Jose Luis Olcoz; Olatz Izaola; Manuel Gonzalez Sagrado; Rosa Conde; Jose Manuel Gonzalez
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

10.  Circulating Fatty Acids Associated with Advanced Liver Fibrosis and Hepatocellular Carcinoma in South Texas Hispanics.

Authors:  Jingjing Jiao; Suet-Ying Kwan; Caroline M Sabotta; Honami Tanaka; Lucas Veillon; Marc O Warmoes; Philip L Lorenzi; Ying Wang; Peng Wei; Ernest T Hawk; Jose Luis Almeda; Joseph B McCormick; Susan P Fisher-Hoch; Laura Beretta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-06-21       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.